Details for New Drug Application (NDA): 065088
✉ Email this page to a colleague
NDA 065088 describes NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, which is a drug marketed by Bausch And Lomb, Padagis Us, and Sciegen Pharms Inc, and is included in three NDAs. It is available from two suppliers. Additional details are available on the NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC profile page.
The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC is bacitracin zinc; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the bacitracin zinc; neomycin sulfate; polymyxin b sulfate profile page.
The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC is bacitracin zinc; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the bacitracin zinc; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 065088
| Tradename: | NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC |
| Applicant: | Sciegen Pharms Inc |
| Ingredient: | bacitracin zinc; neomycin sulfate; polymyxin b sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC | Strength | 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM | ||||
| Approval Date: | Feb 6, 2004 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
